Back to search

Article

Impact of Generic Antiretroviral Drugs Introduction on Pharmaceutical Expenditure Patterns in the Netherlands: A Six-Year Retrospective Database Analysis from 2016 to 2022

2024-02-14

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> In the Netherlands, the annual expenditure on HIV care was 202 million euros in 2019, with about 70% allocated to antiretroviral therapy (ART). The introduction of generic antiretroviral medications (ARVs) in 2017 has offered potential cost-saving opportunities in healthcare. Understanding the financial implications of incorporating generic ART into the Dutch hea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
91da62ad-62e4-57b2-bda2-d31e5f1daf8b
DOI
10.21203/rs.3.rs-3923450/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of Generic Antiretroviral Drugs Introduction on Pharmaceutical Expenditure Patterns in the Netherlands: A Six-Year Retrospective Database Analysis from 2016 to 2022DOI 10.21203/rs.3.rs-3923450/v1
Estimated global cost of treating COVID-19, HIV, Hepatitis B and Hepatitis C with approved effective oral medicationsSemantic proximity
Opportunities for cost reduction of current first-line WHO-recommended oral antiretroviral therapy: replacing tenofovir disoproxil fumarate with tenofovir alafenamideSemantic proximity
Excessive Sales of Pharmaceutical Drugs in a Low and Middle-Income Country During the COVID-19 Pandemic: The Case of EcuadorSemantic proximity
A Study on the Heterogeneous Effects of China’s Volume- Based Procurement on Gastrointestinal and Metabolic MedicationsSemantic proximity
A New Mechanism To Identify Cost Savings in NHS Prescribing: Minimising “Price-Per-Unit”Semantic proximity
Prescription volume and costs of over-the-counter–like drugs in Japan by patient and healthcare facility characteristics: A nationwide descriptive studySemantic proximity
Patients' Attitudes towards Switching to National Volume-Based Procurement (NVBP) Drugs -A Qualitative Investigation in Wuhan, ChinaSemantic proximity
Availability, Prices and Affordability of Nationally Negotiated Antidiabetic Drugs in China: A National SurveySemantic proximity
The impact of the national centralized drug procurement on the use of original and generic targeted anti- tumor drugs in Hohhot, China: an interrupted time-series analysisSemantic proximity
Availability of Different Branded Generic Vildagliptin after Off-patenting: An Observation from Eastern IndiaSemantic proximity
Launch Sequencing of Pharmaceuticals with Multiple Therapeutic Indications: Evidence from Seven CountriesSemantic proximity
Time to Patients’ Access to New Medicines in Greece: Evaluation of Health Technology Assessment (HTA) Process from July 2018 until January 2021.Semantic proximity
Select a neighboring publication to make it the new centre.